Susan Hasty, Publisher
Table of Contents . . . March 31st, 1997Non-Subscriber - Summaries Only
Cancer Gene Therapy - Two Adenovirally Transferred Tumor Suppressor Genes Cooperate in Apoptosis
Brain Cancer - Connexin43 Gene Properties Tapped for Tumor-suppressing
Breast Cancer - Cancer Report Finds Early Detection Saves More Lives
Carcinogenesis - Necroinflammation Critical in Hepatitis-Linked HCC
Cervical Cancer (Screening) - Marketing Agreement Announced To Launch Pap Plus Speculoscopy
Chemotherapy - Pre-Clinical Drug Studies Indicate TNF-(alpha) Inhibition
Disease Markers (Anemia) - INFeD Promoted in Cancer Market
Drug Resistance (Chemotherapy) - Preliminary Phase I Trial Results for Annamycin Announced
Hyperprolactinemia - Dostinex Launched for Benign Tumor-related Disorder
Industry News (Acquisitions) - International Rights Acquired To Commercialize Oncology Product
Industry News (Joint Venture) - Agreement Signed To Produce Albumin in Transgenic Cows
Industry News (Joint Venture) - CRADA Signed in Area of Gene Expression
Industry News (Joint Venture) - Cancer Vaccine Research Collaboration and License Agreement Established
Industry News (Patents and Technology) - Japanese Patent Allowance Notified for Genetic Antisense
Insurance (Viatical Settlements) - Cashing in Early on Life Insurance Policies Getting Tougher
Kaposi's sarcoma - Antisense Inhibitor of KS Growth Stimulator Inhibits Tumor
Kaposi's sarcoma - Promising KS Treatment Data Reported
Oral Mucositis/Stomatitis - Market Clearance Received To Add Indications To Labels
Ovarian Cancer - Cornstarch-Based Feminine Powders Do Not Pose Increased Risk
Pathogenesis - Key to Uncontrolled Growth of Certain Cancers Found
Prostate Cancer (Eulexin) - Complete Hormonal Therapy Maintains Normal Quality Of Life
Suicide Gene Therapy - HSVtk/GCV Gene Therapy Effective against In Vivo Prostate Cancer Model
Suicide Gene Therapy (HCC) - Cytosine Deaminase Gene Therapy Targets Hepatocellular Carcinoma In Vivo
Therapy - Oncolysin B Development Discontinued
Therapy (Radiosurgery) - 'Precision Therapy' Cancer Treatment Available in U.S.
Bone Marrow Transplantation (Leukemia) - "Effect of Prior Interferon Therapy on Outcome of HLA-Identical Sibling Bone Marrow Transplants for Chronic Myelogenous Leukemia (CML) in First Chronic Phase."
Bone Marrow Transplantation (Leukemia) - "Potential for Cure of B-Cell CLL and SLL: Prolonged Disease Free Survival and Molecular Remissions Following Autologous and Allogeneic Bone Marrow Transplantation."
Bone Marrow Transplantation (NHL) - "CD6 Depleted Allogeneic and Syngeneic Bone Marrow Transplantation (BMT) for Non-Hodgkin's Lymphoma."
Cancer Vaccines - "Modified Tumor Cells as Cellular Vaccines."
Kaposi's sarcoma (Pathogenesis) - "Lymphocyte Adhesion and Transmigration Through Kaposi's Sarcoma Cells: Study in Static and Dynamic Flow Models."
Breast Cancer - "Preclinical Studies with Fc gamma R Bispecific Antibodies and Granulocyte Colony-Stimulating Factor-Primed Neutrophils As Effector Cells Against HER-2/neu Overexpressing Breast Cancer."
Cancer Gene Therapy - "Adenovirus-Mediated Herpes Simplex Virus Thymidine Kinase Gene and Ganciclovir Therapy Leads to Systemic Activity Against Spontaneous and Induced Metastasis in an Orthotopic Mouse Model of Prostate Cancer."
Electrochemotherapy - "In vivo Antitumor Effects of Electrochemotherapy in a Hepatoma Model."
Electrochemotherapy - "Novel Electrode Designs for Electrochemotherapy."
Kaposi's sarcoma (KSHV) - "A Single 13-Kilobase Divergent Locus in the Kaposi sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Genome Contains Nine Open Reading Frames That Are Homologous to or Related to Cellular Proteins. D
Kaposi's sarcoma (KSHV) - "Kaposi's sarcoma-Associated Herpesvirus Encodes a Functional Cyclin."
Kaposi's sarcoma (KSHV) - "Strain Variability among Kaposi sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Genomes: Evidence That a Large Cohort of United States AIDS Patients May Have Been Infected by a Single Common Isol
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.